Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPX066 in Parkinson's Disease
NCT00880620Phase 3Completed
- Sponsor
- Impax Laboratories
- Start
- Apr 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of carbidopa + levodopa in Parkinson's disease (PD), sponsored by Impax Laboratories. Started Apr 2009; status: completed.
02
Drugs
carbidopa + levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00880620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00880620.